Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Barrett

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
The Lancet. Psychiatry|February 15, 2026
Brief individual psychological intervention for people with probable personality disorder: a multicentre, researcher-masked, randomised, controlled superiority trial in EnglandMike J Crawford, Verity C Leeson, Rachel Evans, et al.
Lancet (London, England)|July 28, 2016
Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trialDavid A Richards, David Ekers, Dean McMillan, et al.
BMC Psychology|November 25, 2015
Cognitive behaviour therapy for non-cardiac pain in the chest (COPIC): a multicentre randomized controlled trial with economic evaluationPeter Tyrer, Helen Tyrer, Sylvia Cooper, et al.
Health Technology Assessment (Winchester, England)|September 15, 2020
Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCTMichael J Crawford, Lavanya Thana, Rachel Evans, et al.
BMJ (Clinical Research Ed.)|March 1, 2012
Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trialMike J Crawford, Helen Killaspy, Thomas R E Barnes, et al.
Therapeutic Advances in Psychopharmacology|May 5, 2022
The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trialMike J Crawford, Verity C Leeson, Rachel Evans, et al.
The Lancet. Psychiatry|May 16, 2025
Mindfulness-based cognitive therapy versus treatment as usual after non-remission with NHS Talking Therapies high-intensity psychological therapy for depression: a UK-based clinical effectiveness and cost-effectiveness randomised, controlled, superiority trialThorsten Barnhofer, Barnaby D Dunn, Clara Strauss, et al.
Lancet (London, England)|April 25, 2015
Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trialWillem Kuyken, Rachel Hayes, Barbara Barrett, et al.
The International Journal of Neuropsychopharmacology|March 8, 2008
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidenceNorman Sartorius, Thomas C Baghai, David S Baldwin, et al.
Health Technology Assessment (Winchester, England)|September 1, 2017
Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depressionDavid A Richards, Shelley Rhodes, David Ekers, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
The Lancet. Psychiatry|February 15, 2026
Brief individual psychological intervention for people with probable personality disorder: a multicentre, researcher-masked, randomised, controlled superiority trial in EnglandMike J Crawford, Verity C Leeson, Rachel Evans, et al.
Lancet (London, England)|July 28, 2016
Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trialDavid A Richards, David Ekers, Dean McMillan, et al.
BMC Psychology|November 25, 2015
Cognitive behaviour therapy for non-cardiac pain in the chest (COPIC): a multicentre randomized controlled trial with economic evaluationPeter Tyrer, Helen Tyrer, Sylvia Cooper, et al.
Health Technology Assessment (Winchester, England)|September 15, 2020
Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCTMichael J Crawford, Lavanya Thana, Rachel Evans, et al.
BMJ (Clinical Research Ed.)|March 1, 2012
Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trialMike J Crawford, Helen Killaspy, Thomas R E Barnes, et al.
Therapeutic Advances in Psychopharmacology|May 5, 2022
The clinical effectiveness and cost effectiveness of clozapine for inpatients with severe borderline personality disorder (CALMED study): a randomised placebo-controlled trialMike J Crawford, Verity C Leeson, Rachel Evans, et al.
The Lancet. Psychiatry|May 16, 2025
Mindfulness-based cognitive therapy versus treatment as usual after non-remission with NHS Talking Therapies high-intensity psychological therapy for depression: a UK-based clinical effectiveness and cost-effectiveness randomised, controlled, superiority trialThorsten Barnhofer, Barnaby D Dunn, Clara Strauss, et al.
Lancet (London, England)|April 25, 2015
Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trialWillem Kuyken, Rachel Hayes, Barbara Barrett, et al.
The International Journal of Neuropsychopharmacology|March 8, 2008
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidenceNorman Sartorius, Thomas C Baghai, David S Baldwin, et al.
Health Technology Assessment (Winchester, England)|September 1, 2017
Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depressionDavid A Richards, Shelley Rhodes, David Ekers, et al.
Pageof 11